Oxidized LDLs have been implicated in the development of cardiovascular disease (4)
In addition, PCOS has implications beyond reproductive issues, including infertility, miscarriage, and neonatal and pregnancy complications, but also increases the risk of psychological disorders including depression, cardiovascular disease including coronary atherosclerotic heart disease, and metabolic disorders including diabetes ( Many women of reproductive age have a strong desire to become mothers, which is deeply influenced by cultural and religious values in many human communities
Sanofi Industry Developments July 2026: Novo Nordisk received CDSCO approval for Wegovy (semaglutide) as the first and only GLP-1 receptor agonist approved in India for noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis, expanding the drug's indication beyond weight management and type 2 diabetes
This acquisition (closed end-2024) and the side deal transferring three Catalent sites (in Indiana, Belgium, Italy) to Novo Nordisk for $11 billion explicitly aims to expand Wegovy/Ozempic output ( [10] ) ( [11] )
Wakeling J, Elliott J, Petrie A, et al
While both medications target weight through different pathways, combining them raises important safety and efficacy questions that deserve a thorough clinical discussion with your healthcare provider
